The cholinergic anti-inflammatory pathway
暂无分享,去创建一个
[1] K. Tracey,et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation , 2000, Autonomic Neuroscience.
[2] K. Tracey,et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.
[3] R. Bucala,et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor , 2000, Nature Medicine.
[4] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[5] D. Hommes,et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. , 2002, Gastroenterology.
[6] P. Sawchenko,et al. Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.
[7] P. Gross,et al. Sensory circumventricular organs and brain homeostatic pathways , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] V. Pavlov,et al. Neural regulators of innate immune responses and inflammation , 2004, Cellular and Molecular Life Sciences CMLS.
[9] G. Chrousos,et al. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.
[10] M. Sofroniew,et al. Serum Proteins Bypass the Blood-Brain Fluid Barriers for Extracellular Entry to the Central Nervous System , 1993, Experimental Neurology.
[11] A. Sher,et al. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] K. Tracey,et al. HMGB1 in the immunology of sepsis (not septic shock) and arthritis. , 2004, Advances in immunology.
[13] Masaru Sugimachi,et al. Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats , 2003, Circulation.
[14] K. Tracey,et al. From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? , 1999, Shock.
[15] S. Maier,et al. Subdiaphragmatic vagotomy blocks interleukin-1β-induced fever but does not reduce IL-1β levels in the circulation , 2000, Autonomic Neuroscience.
[16] W. Banks,et al. Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier , 1994, Journal of Neuroimmunology.
[17] C. Feighery,et al. Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders , 2002, British journal of biomedical science.
[18] S. Maier,et al. Cytokine-to-brain communication: a review & analysis of alternative mechanisms. , 1995, Life sciences.
[19] M. Herkenham,et al. Area postrema removal abolishes stimulatory effects of intravenous interleukin-1β on hypothalamic-pituitary-adrenal axis activity and c-fos mRNA in the hypothalamic paraventricular nucleus , 1998, Brain Research Bulletin.
[20] T. Strom,et al. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.
[21] M. Wong,et al. Localization of interleukin 1 type I receptor mRNA in rat brain. , 1994 .
[22] C. Miller‐Graziano,et al. Role of elevated monocyte transforming growth factorβ (TGFβ) production in posttrauma immunosuppression , 1991, Journal of Clinical Immunology.
[23] S. Rivest,et al. Toll‐like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram‐negative bacterial cell wall components , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[25] B. Aggarwal,et al. Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.
[26] K. Buller,et al. Circumventricular Organs: Gateways to the Brain Role Of Circumventricular Organs In Pro‐Inflammatory Cytokine‐Induced Activation Of The Hypothalamic– Pituitary–Adrenal Axis , 2001, Clinical and experimental pharmacology & physiology.
[27] K. Tracey,et al. HYPOPHYSECTOMY, HIGH TUMOR NECROSIS FACTOR LEVELS, AND HEMOGLOBINEMIA IN LETHAL ENDOTOXEMIC SHOCK , 1998, Shock.
[28] K. M. Spyer,et al. Central regulation of autonomic functions , 1990 .
[29] W. Banks,et al. Blood to brain transport of interleukin links the immune and central nervous systems. , 1991, Life sciences.
[30] C. Dinarello. The role of interleukin-1 in host responses to infectious diseases. , 1992, Infectious agents and disease.
[31] C. Saper,et al. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain , 1992, The Journal of comparative neurology.
[32] R. Gilmartin,et al. Prospective Long‐Term Study of Vagus Nerve Stimulation for the Treatment of Refractory Seizures , 2000, Epilepsia.
[33] R. Thompson,et al. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.
[34] F. Dudek,et al. Vagally evoked synaptic currents in the immature rat nucleus tractus solitarii in an intact in vitro preparation , 1998, The Journal of physiology.
[35] R. Travagli,et al. Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat , 1999, The Journal of physiology.
[36] D. Altavilla,et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. , 2004, Cardiovascular research.
[37] F. Balkwill. Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.
[38] E. Wada,et al. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] K. Tracey,et al. Spermine Inhibits Proinflammatory Cytokine Synthesis in Human Mononuclear Cells: A Counterregulatory Mechanism that Restrains the Immune Response , 1997, The Journal of experimental medicine.
[40] F. Heinzel. The role of IFN-gamma in the pathology of experimental endotoxemia. , 1990, Journal of immunology.
[41] P. Szlosarek,et al. Tumour necrosis factor α: a potential target for the therapy of solid tumours , 2003 .
[42] R. Gamelli,et al. PARTIAL HEPATECTOMY REDUCES THE ENDOTOXIN-INDUCED PEAK CIRCULATING LEVEL OF TUMOR NECROSIS FACTOR IN RATS , 1996, Shock.
[43] M. Satoh,et al. Localization of type I interleukin-1 receptor mRNA in the rat brain. , 1994, Brain research. Molecular brain research.
[44] C. Szabó,et al. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. , 1998, Biochemical pharmacology.
[45] J. Norton,et al. Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia , 1993, The Journal of experimental medicine.
[46] Hong Wang,et al. The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation , 2003, Molecular medicine.
[47] J. Blalock,et al. Harnessing a Neural-immune Circuit to Control Inflammation and Shock , 2002, The Journal of experimental medicine.
[48] P. Waring,et al. Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. , 1994, The Journal of infectious diseases.
[49] A. Weindl,et al. Peering through the Windows of the Brain , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] Yasuyoshi Watanabe,et al. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever , 1996, Brain Research.
[51] G. V. Poole,et al. Tumor Necrosis Factor α Gene Expression in Human Peritoneal Macrophages Is Suppressed by Extra-abdominal Trauma , 1995 .
[52] N. Birdsall,et al. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.
[53] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[54] S. Maier,et al. Vagal immune-to-brain communication: a visceral chemosensory pathway , 2000, Autonomic Neuroscience.
[55] Hong Wang,et al. Spermine Inhibition of Monocyte Activation and Inflammation , 1999, Molecular medicine.
[56] K. Tracey,et al. CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[57] K. Tracey,et al. HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.
[58] K. Tracey,et al. Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules , 1998 .
[59] S. Maier,et al. TNF-α–Induced Corticosterone Elevation But Not Serum Protein or Corticosteroid Binding Globulin Reduction Is Vagally Mediated , 1997, Brain Research Bulletin.
[60] M. Atkins,et al. A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[61] K. Tracey,et al. Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway , 2002, The Journal of experimental medicine.
[62] L. Minutoli,et al. Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-&kgr;B Activation and Protects Against Hypovolemic Hemorrhagic Shock , 2003, Circulation.
[63] P. Sawchenko,et al. Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1 , 1997, The Journal of Neuroscience.
[64] L. Moldawer,et al. BLOCKADE OF TUMOR NECROSIS FACTOR REDUCES LIPOPOLYSACCHARIDE LETHALITY, BUT NOT THE LETHALITY OF CECAL LIGATION AND PUNCTURE , 1995, Shock.
[65] W. Banks,et al. Blood–Brain Barrier Permeability to Ebiratide and TNF in Acute Spinal Cord Injury , 1997, Experimental Neurology.
[66] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[67] D. McTigue,et al. Vagal control of digestion: Modulation by central neural and peripheral endocrine factors , 1996, Neuroscience & Biobehavioral Reviews.
[68] W. Banks,et al. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse , 1993, Journal of Neuroimmunology.
[69] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-β , 1988, Nature.
[70] A. Satoskar,et al. Targeted Disruption of Migration Inhibitory Factor Gene Reveals Its Critical Role in Sepsis , 1999, The Journal of experimental medicine.
[71] A. Terano,et al. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats , 2005, Regulatory Peptides.
[72] Mustafa M. Husain,et al. Vagus nerve stimulation: a new tool for brain research and therapy∗ , 2000, Biological Psychiatry.
[73] K. Tracey,et al. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[74] S. Rivest,et al. Effect of Acute Systemic Inflammatory Response and Cytokines on the Transcription of the Genes Encoding Cyclooxygenase Enzymes (COX‐1 and COX‐2) in the Rat Brain , 1998, Journal of neurochemistry.
[75] H. Langstein,et al. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. , 1992, Journal of immunology.
[76] S. Anker,et al. Vagal nerve stimulation in chronic heart failure: an antiinflammatory intervention? , 2004, Circulation.
[77] Kevin J. Tracey,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.
[78] J. Lindstrom. Nicotinic acetylcholine receptors in health and disease , 1997, Molecular Neurobiology.
[79] M. Feldmann,et al. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases , 2003, Nature Medicine.
[80] K. Tracey,et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia , 1993, Nature.
[81] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[82] A. Maelicke,et al. Choline is a Selective Agonist of α7 Nicotinic Acetylcholine Receptors in the Rat Brain Neurons , 1997, The European journal of neuroscience.
[83] K. Tracey,et al. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. , 1994, Annual review of medicine.
[84] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[85] K. Tracey,et al. TUMOR NECROSIS FACTOR IS A BRAIN DAMAGING CYTOKINE IN CEREBRAL ISCHEMIA , 1997, Shock.
[86] Hong Wang,et al. Regulation of macrophage activation and inflammation by spermine: a new chapter in an old story. , 2000, Critical care medicine.
[87] A. Korczyn,et al. The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice , 2002, Progress in Neurobiology.
[88] A. Kastin,et al. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 α across the blood-brain barrier , 1996, Journal of Neuroimmunology.
[89] Kevin J. Tracey,et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.